Professional Documents
Culture Documents
Full download Neurology secrets 6th Edition Eli M. Mizrahi (Editor) file pdf all chapter on 2024
Full download Neurology secrets 6th Edition Eli M. Mizrahi (Editor) file pdf all chapter on 2024
Mizrahi (Editor)
Visit to download the full and correct content document:
https://ebookmass.com/product/neurology-secrets-6th-edition-eli-m-mizrahi-editor/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://ebookmass.com/product/anesthesia-secrets-6th-edition-
brian-m-keech/
https://ebookmass.com/product/anesthesia-secrets-6th-edition-
edition-brian-keech/
https://ebookmass.com/product/swaimans-pediatric-neurology-6th-
edition-edition-kenneth-f-swaiman/
https://ebookmass.com/product/dermatology-secrets-6th-edition-
whitney-a-high/
Medical secrets 6th Edition Mary P. Harward
https://ebookmass.com/product/medical-secrets-6th-edition-mary-p-
harward/
https://ebookmass.com/product/cardiology-secrets-6th-edition-
glenn-n-levine/
https://ebookmass.com/product/swaimans-pediatric-neurology-
principles-and-practice-6th-edition-kenneth-f-swaiman/
https://ebookmass.com/product/critical-care-secrets-6th-edition-
renee-doney-stapleton-editor/
https://ebookmass.com/product/m-business-6th-edition-ebook-pdf/
NEUROLOGY
SIXTH EDITION
JOSEPH S. KASS, MD, JD
Associate Professor
Departments of Neurology and Psychiatry & Behavioral Sciences
Center for Medical Ethics & Health Policy
Vice Chair for Education
Department of Neurology
Assistant Dean of Student Affairs
Baylor College of Medicine;
Chief of Neurology
Ben Taub General Hospital
Houston, Texas
ELI M. MIZRAHI, MD
Chair
Department of Neurology
Professor
Departments of Neurology and Pediatrics
James A. Quigley Endowed Chair in Pediatric Neurology
Baylor College of Medicine
Houston, Texas
1600 John F. Kennedy Blvd.
Ste 1800
Philadelphia, PA 19103-2899
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechani-
cal, including photocopying, recording, or any information storage and retrieval system, without permission in
writing from the publisher. Details on how to seek permission, further information about the Publisher’s permis-
sions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copy-
right Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other
than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience broaden
our understanding, changes in research methods, professional practices, or medical treatment may become
necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds, or experiments described herein. In using such information or
methods they should be mindful of their own safety and the safety of others, including parties for whom they
have a professional responsibility.
With respect to any drug or pharmaceutical products identified, readers are advised to check the most
current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be
administered, to verify the recommended dose or formula, the method and duration of administration, and
contraindications. It is the responsibility of practitioners, relying on their own experience and knowledge of
their patients, to make diagnoses, to determine dosages and the best treatment for each individual patient,
and to take all appropriate safety precautions.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume
any liability for any injury and/or damage to persons or property as a matter of products liability, negligence
or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the
material herein.
vii
viii Contributors
The first edition of Neurology Secrets was published over 20 years ago. The subsequent editions have
tracked the dramatic advances in the field of neurology. In this 6th edition, each chapter has been revised
and updated to reflect the current state of the art and science of the topic. New chapters have been added
that emphasize the multidisciplinary nature of the practice of neurology. The purpose of this book is to
focus on the fundamental issues of the field of neurology. This edition follows the now familiar N eurology
Secrets format with each chapter organized as a series of questions and answers. Key points are high-
lighted in each chapter. The chapters are developed to form a basis for further discussion with directed
references and reading for more in-depth review. Each chapter is designed to provide the reader with a
concise and accurate review which crystallizes the essential features of each topic.
We are indebted to the contributors of Neurology Secrets 6th edition. Most of these authors have
some academic relationship to Baylor College of Medicine in Houston, Texas, either as current or former
faculty members or trainees. This is a tradition begun with the first edition and has continued through the
subsequent editions. Some are new to this edition; however, there are a number who have been contribut-
ing from the start.
The founding editor of Neurology Secrets, Loren A. Rolak, MD, who also edited the subsequent editions,
relinquished that role for this 6th edition—although he continues as a contributor. He began this effort
within the context of his role as member of the faculty and Neurology Residency Program Director, Depart-
ment of Neurology, at Baylor College of Medicine in Houston, Texas. Throughout the years, Dr Rolak, who is
now at Marshfield Clinic in Marshfield, Wisconsin, has been committed to medical education. The previous
editions of Neurology Secrets are, in part, evidence of his dedication and skill as an educator, and we trust
that the 6th edition does justice to the rich tradition he established.
xiii
xiv Top 100 Secrets
21. The first seven cervical nerves exit above the vertebral body with the eight exiting below
C7, and the remainder of the spinal roots exit below their corresponding vertebral body.
22. Transverse myelitis is an inflammatory process that is localized over several segments
of the cord functionally transects the cord.
23. The most common metastatic tumors to the spinal cord are breast, lung, gastrointesti-
nal tract, lymphoma, myeloma, and prostate.
24. A unilateral lesion within the brainstem often causes “crossed syndromes,” in which
ipsilateral dysfunction of one or more cranial nerves is accompanied by hemiparesis
and/or hemisensory loss on the contralateral body.
25. Symptoms of brainstem ischemia are usually multiple, and isolated findings (such as
vertigo or diplopia) are more often caused by peripheral lesions affecting individual
cranial nerves.
26. Brainstem glioma is the most frequent brainstem neoplasm. Other brainstem neo-
plasms include ependymomas that occur in the fourth ventricle and metastatic lesions
that may originate from malignant melanomas or carcinomas of the lung and breast.
27. Ménière’s disease presents with the symptomatic triad of episodic vertigo, tinnitus, and
hearing loss. It is caused by an increased amount of endolymph in the scala media.
Pathologically, hair cells degenerate in the macula and vestibule.
28. Central pontine myelinolysis (osmotic demyelination syndrome) occurs primarily in patients
suffering from malnutrition or alcoholism complicated by hyponatremia. Rapid correction
of the hyponatremia has been implicated as a cause of the pathologic abnormality.
29. Cerebellar strokes and hemorrhage may result in a neurological/neurosurgical emer-
gency by causing obstructive hydrocephalus.
30. Episodic ataxia type 2 is caused by mutations in the same gene (CACN1A4) as familial
hemiplegic migraine and spinocerebellar ataxia type 6.
31. Differential diagnosis of cerebellar/ataxic conditions can vary by age: (1) adults are more
likely to have autosomal dominant spinocerebellar ataxias, degenerative forms of ataxia,
extra-axial tumors, paraneoplastic syndromes, and vascular insults to the cerebellum;
(2) pediatric patients are more likely to manifest with autosomal recessive cerebellar
ataxias, intra-axial cerebellar tumors, infections, or congenital/developmental
abnormalities.
32. Levodopa remains the most effective therapy for Parkinson’s disease, but management
of levodopa-related complications continues to be a challenging probelm that often
requires treatment with multiple medications and deep brain stimulation.
33. Essential tremor is a familial disorder, but the genes responsible for this alcohol-
responsive action tremor have not yet been identified.
34. Cardinal symptoms of autonomic insufficiency include orthostatic hypotension, bowel
and bladder dysfunction, impotence, and sweating abnormalities.
35. Autonomic failure can be seen in the setting of systemic peripheral neuropathies, the
most common being diabetic neuropathy, or can be seen without involvement of the
sensorimotor neurons, such as pure autonomic failure. Some dysautonomias have
autoimmune etiology.
36. The diagnosis of multiple sclerosis requires lesions disseminated in time and in space:
two separate symptoms at two separate times.
37. Faulty interpretation of magnetic resonance imaging is the most common error leading
to the misdiagnosis of multiple sclerosis.
38. No treatment has yet been proven to alter the level of long-term disability in multiple
sclerosis.
Top 100 Secrets xv
39. Dementia is a category, not a diagnosis, and Alzheimer’s disease is the most common
form of dementia.
40. Most causes of dementia are treatable even if not curable.
41. Frontotemporal dementia (FTD) can present with either behavioral symptoms or primary
progressive aphasia.
42. Progressive supranuclear palsy and corticobasal syndrome are parkinsonian disorders
associated with dementia and tau aggregation.
43. Cerebral amyloid angiopathy can cause dementia and has manifestations apart from
classic lobar hemorrhage.
44. Ten to 15% of patients with amnestic mild cognitive impairment progress to develop-
ment of Alzheimer’s disease each year.
45. Repetitive mild traumatic brain injury can lead to a syndrome of progressive cognitive
decline, behavioral and mood changes, and motor/parkinsonian symptoms known as
chronic traumatic encephalopathy. The diagnosis can only be confirmed postmortem
by identification of hyperphosphorylated tau protein deposits in the sulci.
46. The diagnosis of posttraumatic stress disorder requires exposure to trauma with
development of symptoms (intrusive thoughts, re-experiencing, avoidance, nega-
tive alterations in cognition and mood, and marked alterations in arousal and
reactivity) lasting >1 month and causing significant distress and/or impairment in
functioning.
47. A
n acute onset of cognitive decline with fluctuations in orientation and level of alertness
is the hallmark of delirium rather than indicative of dementia.
48. The main clinical feature of stroke is sudden onset of a focal neurological deficit.
49. The only Food and Drug Administration-approved treatment for acute ischemic stroke
is intravenous (IV) tissue plasminogen activator, administered within 3 hours of the time
the patient was last seen normal.
50. Hemorrhagic strokes often present with a diminished level of consciousness; ischemic
strokes rarely do.
51. A depressed level of consciousness (Glascow Coma Scale <8) is the greatest risk fac-
tor for airway obstruction and aspiration.
52. Think of cerebral amyloid angiopathy as the most likely cause of spontaneous lobar
intracerebral hemorrhage in patients age >55 years.
53. Nimodipine in aneurismal subarachnoid hemorrhage is neuroprotective as it improves
outcome but has not shown to reduce vasospasm.
54. Early decompressive hemicraniectomy after large hemispheric ischemic stroke within
48 hours for patients <60 years of age improves survival and functional outcome.
55. Steroids are not recommended in Guillain–Barré syndrome.
56. Treat convulsive status epilepticus early and aggressively with benzodiazepines
57. Brain death is a clinical diagnosis.
58. Central nervous system (CNS) tumors are classified into four grades according to the
World Health Organization (WHO) grading system.
59. Glioblastoma (Grade IV astrocytoma) is the most common and malignant primary brain
tumor in adults.
60. Brain metastases are the most common intracranial tumors in adults, occurring nearly
10 times more often than primary brain tumors.
xvi Top 100 Secrets
61. Intrathecal methotrexate use has been associated with aseptic meningitis, transverse
myelopathy, encephalopathy, and leukoencephalopathy.
62. Do not prescribe opioid or butalbital-containing medications as first-line treatment for
recurrent headache disorders.
63. The risk of postdural puncture headache can be greatly reduced by use of an atrau-
matic needle. Bedrest following the procedure is not preventive.
64. Headache or neck pain is the only symptom of cervical artery dissection in 8% of
individuals.
65. A seizure is a single event, while epilepsy refers to (1) recurrent unprovoked seizures,
(2) a single seizure with a high risk for recurrent seizures, or (3) recurrent reflex seizures.
66. Epilepsy surgery has the best outcomes in patients with a structural lesion (80%) or
those with temporal lobe epilepsy (60% to 70%).
67. Medication-refractory (pharmacoresistant) epilepsy is diagnosed when two or three
antiepileptic medications at appropriate doses fail to control seizures.
68. Sleep problems occur frequently in individuals with uncomplicated medical histories
(20% to 40%) and very frequently in children and adults with complicated medical
histories (40% to 80%).
69. All patients with a stroke must have screening for cardiovascular disease.
70. Patients with uremia often develop a metabolic encephalopathy with signs of neuronal
depression such as lethargy as well as excitation such as myoclonus.
71. Most patients with Cushing’s disease have frank weakness with myopathic findings on
electromyography.
72. Decompensated hypothyroidism can cause myxedema coma with mortality rates as
high as 25% to 60%.
73. Cerebrovascular ischemic events occur 13 times more frequently in pregnant women
than in age-matched nonpregnant women.
74. Headache, jaw claudication, and constitutional symptoms compose the triad of clinical
symptoms often found in temporal arteritis.
75. Patients suspected of having bacterial meningitis should receive adjunctive dexa-
methasone along with empiric antibiotics. The dosing regimen is dexamethasone 4 mg
IV every 6 hours for 4 days with the first dose given either 30 minutes prior to the first
dose of antibiotics or concomitantly with the first dose of antibiotics. If the CSF cultures
indicate the pathogen is not Streptococcus pneumoniae, then dexamethasone may be
discontinued.
76. Herpes simplex virus-1 (HSV-1) encephalitis should be considered in a patient present-
ing with fever, behavioral changes, and/or seizures and should be treated empirically
with IV acyclovir. HSV polymerase chain reaction in CSF can be negative in the first few
days of infection, necessitating repeating lumbar puncture 3 or more days after
infection onset.
77. The differential diagnosis for a ring-enhancing lesion in a person with Acquired Immu-
nodeficiency Syndrome includes most commonly Toxoplasma gondii and primary CNS
lymphoma but also includes tuberculoma, cryptococcoma, histoplasmoma, and other
fungal infections, bacterial brain abscess, metastatic disease, and primary brain tumor.
78. Neurocysticercosis is the most common infectious cause of epilepsy with treatment
strategies varying depending on cyst life cycle stage and location within the nervous
system.
79. The possibility of multiple mutation mechanisms should be considered in ordering and
interpreting diagnostic test results for many neurogenetic diseases.
Top 100 Secrets xvii
INTRODUCTION
1. Why is it important to understand the cellular, molecular, and genetic mechanisms
that govern normal and abnormal nervous system function?
• To select the most appropriate diagnostic tests and interpretation of test results
• To optimize drug therapy by mechanisms of action, interactions, side effect profiles
• To educate patients and their families about their diseases and prognoses
• To aid in the critical review of rational drug design and clinical trials
2. What cellular alterations lead to neurological disease or affect management/
prognosis?
• Loss of neurons (e.g., neurodegenerative conditions)
• Injury of axons (e.g., traumatic brain injury)
• Reorganization of synaptic connections (e.g., deafferentation pain)
• Disruption of the blood–brain barrier (BBB) (e.g., stroke)
3. What molecular alterations lead to neurological disease or affect management/
prognosis?
• Excitation–contraction uncoupling (e.g., channelopathies)
• Dysfunctional volume regulation (e.g., cytotoxic edema)
• Altered membrane excitability (e.g., epilepsy)
• Conduction abnormalities (e.g., demyelinating conditions)
• Oxidative stress (e.g., mitochondrial disorders)
• Autoimmune attack of receptors (e.g., myasthenia gravis)
4. Why is the presence of genetic alterations relevant in neurologic diseases?
• They may reveal propensity for decreased drug efficacy.
• They may reveal susceptibility to drug toxicity.
• They may provide presymptomatic diagnoses.
• They may be prognostic.
CELLULAR ANATOMY
5. What are the major subcellular compartments of the canonical neuron (Fig. 1-1)?
• Soma—body of the neuron
• Dendrites—processes that emanate from the soma and subserve synaptic connections
• Axon—projection from the soma that terminates on postsynaptic partners
• Nodes of Ranvier—area between myelinated axonal segments densely populated by voltage-gated
Na+ channels that regenerate action potentials
• Myelin—a sheath comprised primarily of lipids that electrically insulates the axon and allows for
salutatory conduction at unsheathed nodes
6. How are the major subcellular compartments of the canonical neuron affected
in disease?
• Soma—site of pathological inclusions in neurodegenerative diseases
• Dendrites—loss of dendritic spines in autism
• Axon—susceptibility to shearing in traumatic brain injury, loss in Wallerian degeneration
• Nodes of Ranvier—susceptibility to dysfunction in channelopathies
• Myelin—loss in demyelinating diseases
7. What are the major cell types in the nervous system?
• Neurons—These comprise a diverse collection of cells that marry afferent input to internal brain
states to produce perception and behavior.
1
2 Chapter 1 Clinical Neuroscience
Node of Ranvier
Axon
Figure 1-1. The canonical neuron consists of a soma, dendrites, and axon ensheathed in myelin and punctuated by nodes
of Ranvier.
• Glia—These comprise a diverse collection of cells that support neuronal function and are believed
more recently to participate actively in synaptic formation and function.
8. List the major types of neurons in the nervous system.
• Excitatory glutamatergic pyramidal neurons—80% of neocortical neurons, long range
• Inhibitory gamma aminobutyric acid-ergic (GABAergic) interneurons—20% of neocortical neurons,
mostly local
• Neuromodulatory neurons—neurons expressing acetylcholine, dopamine, serotonin, norepineph-
rine, epinephrine, histamine, and neuropeptides such as orexin/hypocretin, somatostatin that often
also corelease the classical neurotransmitters glutamate or GABA.
9. List the major types of glia in the nervous system.
• Astrocytes—establish the blood–brain barrier, flux ions, repair and form scars in injury
• Oligodendroglia and Schwann cells—form myelin in brain/spinal cord and periphery
• Ependymal cells—neuroepithelial cells lining the ventricles, choroid, spinal cord central canal, form
cerebrospinal fluid, nonrenewing stem cell pool producing neurons in adult central nervous system
(CNS) injury
• Microglia—resident inflammatory phagocytes in infection, degeneration, demyelination
K EY POIN T S: C E L L T YP E -S P E C I F I C DY S F UN C T I O N O R L OS S IN
N EUR OL OGIC D IS E ASE
1. Excitatory cortical neurons are preferentially lost in Alzheimer’s disease (AD).
2. Inhibitory cortical neurons are preferentially affected in epilepsy.
3. Neuromodulatory neurons are preferentially lost in AD (acetylcholine), Parkinson’s disease (PD)
(dopamine), and narcolepsy (orexin/hypocretin).
4. Astrocytes are preferentially affected in Alexander’s disease and neuromyelitis optica.
5. Oligodendroglia and Schwann cells are preferentially affected in multiple sclerosis and
Charcot–Marie–Tooth disease, respectively.
10. What are the cellular constituents of the blood-brain barrier (BBB) (Fig. 1-2)?
• Capillary endothelial cells—linked by tight junctions and expressing ion channels, carrier-mediated
and lipid-soluble transporters, efflux pumps
• Pericapillary astrocytes—end-feet adjacent to capillaries
• A similar system exists for the choroidal epithelium at the blood–cerebrospinal fluid barrier (BCSFB)
(Fig. 1-3).
Basement membrane
Tight junctions
Endothelial
cells
Astrocyte
Transporters
Figure 1-2. The blood–brain barrier (BBB) consists of endothelial cells bound by tight junctions and surrounded by
astrocytic and pericytic (not pictured) processes.
Tight junctions
Choroidal epithelium
Figure 1-4. Computerized tomography (CT) scan of the brain without contrast reveals radiodense blood surrounded by
radiolucent vasogenic edema.
Figure 1-5. Magnetic resonance imaging (MRI) of the brain. T1 contrast reveals hyperintense enhancement of a tumor
from leakage of blood across a compromised BBB. T2 gradient recalled echo (GRE) reveals hypointense hemosiderin
deposition of blood. T2 fluid-attenuated inversion recovery (FLAIR) reveals hyperintense edema.
MOLECULAR NEUROBIOLOGY
17. What ionic currents support action potential generation and propagation?
• Depolarizing phase—Na+ currents
• Repolarizing phase:
Inactivation of Na+ currents (accounts for refractory period of action potentials)
•
Activation of K+ currents (accounts for membrane hyperpolarization)
•
Chapter 1 Clinical Neuroscience 5
“Hold, you wasteful little fellow!” cried his grandpapa. “I did not tell
you to root up my field at one stroke. Let me see, however. Observe
what a wonderful increase here is. These seven stalks have all
sprung from one single grain, and each ear contains, perhaps,
twenty grains; which gives us in all a hundred and forty grains
instead of one.”
Arthur. That is astonishing, indeed! So there always grows a
hundred and forty times as much wheat as is sown?
Mr. Mansfield. No, no, I did not say that. In this instance it is so;
and sometimes it may even happen to produce more; but a great
deal of seed rots in the ground, without ever growing at all: of what
does come up, some is spoilt before it is ripe, and the ears that come
to perfection do not all yield so well as these. I believe, therefore,
that taking the kingdom throughout, we only gather about eight times
the quantity we sow.
Arthur. How long is wheat growing, pray, sir?
Mr. Mansfield. Nine or ten months generally. No sooner is the
harvest of one year got in, than we begin to prepare for that of the
ensuing year. We plough the land, and sow it again immediately.
Some seed, indeed, is not sown before the spring, but that never
produces quite such good crops.
Charles. What is the use of ploughing, grandpapa?
Mr. Mansfield. To break up the earth, which would otherwise get so
hard that no corn could grow in it. When a field has been ploughed, a
man walks over it, and scatters the seed all over the field. Then it is
raked in by an instrument full of great iron teeth, called a harrow.
Care must afterwards be taken to keep it free from weeds, but
besides that nothing more can be done. It is left for the rain to water,
and the sun to ripen it.
Charles. And when it is quite ripe, then the harvest comes, does it
not, sir?
Mr. Mansfield. Yes. Then the reapers go into the field, and cut
down the corn with their sickles. They tie it up in bundles, which are
called sheaves, when it is carried into barns, and thrashed out for
use.
As they were conversing in this manner they arrived at the mill;
and when Mr. Mansfield had given his orders, he asked leave to lead
his grandchildren over it. He then explained to them, how the sails,
being turned round by the wind, were the occasion of turning
different wheels in the inside of the building. He next pointed out to
them two large flat stones, shut up in a kind of box. “You may see,”
said he, “that all the corn is made to pass between these stones. The
understone is fixed; but the upper one turns round, and presses so
heavily upon it, as to bruise and grind the corn to powder.”
“I understand you, grandpapa,” returned Charles. “And is that all
that is done here?”
Mr. Mansfield. Not all, Charles; for the corn, though ground into
meal, wants sifting. To do that, there is a contrivance called a
boulting engine, and you may look at it if you step this way.
Mr. Mansfield then opened a little door in the large wooden box, or
bin, that contained the engine; when a quantity of fine flour flew out
into their faces, and powdered them all over. The boulter was made
of frame-work, five or six feet long, round which a canvas was tightly
strained. “Now,” said Mr. Mansfield, “the meal is put into this boulting
machine, which turns round, you see, very fast when the mill is at
work. The quickness of its motion causes the fine flour to fly off
through the canvas; but the coarse and husky part, which is bran,
not being able to do that, falls to the bottom by itself. The use of
shutting it up in this box, is to prevent the flour from being scattered
over the mill.”
The Bensons and their grandfather remained at the mill till they
had thoroughly examined every part of it. They received much
pleasure from seeing the different wheels and contrivances, and
were diverted to find, when they came away, that they were so
covered with flour as to look almost as white as millers.
As they were returning home, Arthur observed, that having first
seen the wheat growing, and afterwards ground, they only wanted
now to know how flour was made into bread, to understand the
whole process from beginning to end.
Mr. Mansfield replied, that he could easily explain that. The flour
was mixed with a proper quantity of water, and a little yeast put in to
make it rise. “This,” said he, “is well kneaded together, and then it is
put into an oven and baked.”
“But what is yeast?” inquired Charles.
Mr. Mansfield. A scum that rises on the top of new beer.
Arthur. Have not I, sir, seen to-day, some of all the different kinds
of corn that grow here?
Mr. Mansfield. I do not recollect our having met with oats. They do
not grow in one compact ear like the rest, for every grain has a
separate little foot-stalk to itself. In this part of the country they are
chiefly given to horses; but in Scotland, and the north of England,
oatmeal cakes are frequently eaten instead of bread.
“And now,” continued he, “I am not sorry to find myself near home.
You, Arthur, may likewise be glad to rest yourself, for you have been
stumping about almost all day.”
The boys declared they were not at all tired, and thanked their
grandpapa for the pleasure he had procured them.
CHAPTER IX.
Poultry.